Oral Micronized Progesterone Cost in Mississippi (2026)

What Oral Micronized Progesterone Costs in Mississippi Right Now

The average cash price for generic oral micronized progesterone at Mississippi retail pharmacies in 2026 is $45 per month for a standard 100 mg or 200 mg daily supply. Brand-name Prometrium carries a manufacturer list price of $180 per month, though very few patients pay this figure out of pocket.

That $45 generic price sits close to the national average. A 2024 analysis of pharmacy benefit costs found that generic progesterone capsules ranged from $30 to $65 across U.S. markets, depending on the dispensing pharmacy and quantity [1]. Mississippi falls in the middle of that band. Rural pharmacies in the Delta region may charge slightly more due to lower prescription volume and higher wholesale acquisition costs, while pharmacies in the Jackson metro area and along the Gulf Coast tend to price closer to $40.

Compounded oral micronized progesterone from a licensed 503A compounding pharmacy in Mississippi averages $25 per month. This option requires a patient-specific prescription. The FDA defines 503A pharmacies as traditional compounding operations that fill individual prescriptions, distinct from 503B outsourcing facilities that produce larger batches [2]. Both categories operate legally in Mississippi, giving patients a lower-cost alternative when a prescriber determines that compounded progesterone is clinically appropriate.

Price comparison matters here. The difference between $180 (brand), $45 (generic), and $25 (compounded) per month adds up to between $240 and $1 to 860 in annual savings depending on which option a patient selects. For women on long-term HRT who need continuous endometrial protection, that cost gap compounds over years of therapy.

Why Progesterone Is Prescribed and What the Evidence Shows

Oral micronized progesterone serves a specific clinical role: protecting the uterine lining in women taking estrogen therapy. Without progesterone opposition, unopposed estrogen increases the risk of endometrial hyperplasia and endometrial cancer. The data on this point is unambiguous.

The PEPI Trial (Postmenopausal Estrogen/Progestin Interventions, N=875) published in JAMA in 1995 established oral micronized progesterone as an effective and well-tolerated option for endometrial protection [3]. Women randomized to conjugated equine estrogen plus micronized progesterone (200 mg cyclically for 12 days per month) had no excess endometrial hyperplasia compared to placebo over three years. The trial also showed that micronized progesterone preserved the favorable HDL cholesterol effects of estrogen better than medroxyprogesterone acetate (MPA) did.

The Endocrine Society's 2015 clinical practice guideline on menopausal hormone therapy recommends that "women with an intact uterus who use estrogen therapy should also use a progestogen to prevent endometrial hyperplasia" [4]. The guideline specifically identifies micronized progesterone as an acceptable progestogen option, noting its neutral-to-favorable cardiovascular and breast safety profile relative to synthetic progestins.

Dr. JoAnn Manson, principal investigator of the WHI hormone therapy trials and professor at Harvard Medical School, has stated: "Micronized progesterone appears to have a more favorable safety profile than medroxyprogesterone acetate, particularly with respect to breast cancer risk and cardiovascular outcomes" [5]. This distinction influences prescribing patterns, especially for women weighing long-term HRT use.

The FDA-approved labeling for Prometrium indicates its use for prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving conjugated estrogens, and for treatment of secondary amenorrhea [6]. Standard dosing for endometrial protection is 200 mg orally at bedtime for 12 consecutive days per 28-day cycle (cyclic regimen) or 100 mg nightly (continuous regimen).

Mississippi Medicaid and Oral Micronized Progesterone

Mississippi Medicaid does not cover oral micronized progesterone for endometrial protection on hormone replacement therapy as of 2026. This coverage gap affects a significant number of women in the state.

Mississippi has one of the highest rates of uninsured and Medicaid-dependent adults in the country. According to Kaiser Family Foundation data, approximately 23% of Mississippi women ages 19 to 64 were enrolled in Medicaid or CHIP as of 2024 [7]. For these women, the lack of Medicaid coverage for progesterone in the HRT context means paying out of pocket or forgoing endometrial protection entirely. Neither option is ideal.

The coverage exclusion applies specifically to the HRT indication. Mississippi Medicaid may cover progesterone for other FDA-approved indications, such as secondary amenorrhea, under different utilization management criteria. Patients and prescribers should verify coverage through the Mississippi Division of Medicaid's preferred drug list, which is updated quarterly. The distinction between covered and non-covered indications can be confusing, and a prior authorization request citing a non-HRT diagnosis code may receive approval when an HRT-related code would not.

For patients who lose Medicaid eligibility due to redetermination or income changes, the transition to uninsured status makes the $45 generic or $25 compounded price points especially relevant. Continuity of progesterone therapy matters. Abrupt discontinuation in women taking continuous combined HRT can cause withdrawal bleeding and, over time, may leave the endometrium unprotected if estrogen continues.

Insurance Coverage Beyond Medicaid

Commercial insurance plans in Mississippi generally cover generic oral micronized progesterone, though copay amounts vary by plan tier and formulary placement. Most plans place generic progesterone on Tier 1 or Tier 2, resulting in copays between $5 and $25 per month.

Brand-name Prometrium typically sits on Tier 3 (preferred brand) or Tier 4 (non-preferred brand) with copays ranging from $35 to $75. Some plans require step therapy, meaning the patient must try and fail generic progesterone before the plan will cover brand Prometrium. Given that the generic is bioequivalent, step therapy rarely presents a clinical barrier.

The AACE/ACE 2017 guidelines on menopause management note that "the choice of progestogen should be individualized based on clinical profile, side effect tolerance, and cost" [8]. For Mississippi patients on commercial insurance, generic micronized progesterone almost always represents the most cost-effective covered option.

Mississippi's Blue Cross Blue Shield, the state's largest commercial insurer, includes generic progesterone on its standard formulary. UnitedHealthcare, Humana, and Aetna plans sold on the Health Insurance Marketplace in Mississippi similarly cover the generic. Patients enrolled in Medicare Part D plans should check their specific plan formulary, as coverage and copay tiers vary across the dozens of Part D plans available in the state.

How to Get the Lowest Price in Mississippi

Several strategies can reduce the cost of oral micronized progesterone below the $45 average cash price.

Compounded progesterone from a 503A pharmacy. At approximately $25 per month, compounded progesterone is the cheapest option available in Mississippi. Patients need a prescription written specifically for compounded progesterone. The prescriber must specify the dose, form (typically oral capsules in peanut oil or olive oil base), and quantity. Mississippi Board of Pharmacy regulations permit 503A compounding pharmacies to prepare patient-specific prescriptions, and several compounding pharmacies operate in Jackson, Hattiesburg, and the Gulf Coast region [2].

Manufacturer savings cards. The Prometrium manufacturer offers a savings card that can reduce brand copays for commercially insured patients. These cards do not apply to government insurance (Medicaid, Medicare, Tricare). Savings vary, but typical cards reduce copays by $25 to $50 per fill. Patients can check the manufacturer's website or ask their pharmacy about available programs.

Pharmacy discount programs. GoodRx, RxSaver, and similar platforms aggregate discount pricing across Mississippi pharmacies. Generic progesterone 100 mg (30 capsules) frequently prices at $15 to $30 through these programs, which is below the $45 average cash-pay figure. Walmart's $4/$10 generic list historically included progesterone, though availability and pricing should be confirmed at individual locations.

Patient assistance programs. For uninsured patients with household incomes below 200% of the federal poverty level (about $31,200 for a single person in 2026), some manufacturer and nonprofit assistance programs provide progesterone at no cost. NeedyMeds and RxAssist maintain databases of available programs [9].

Mail-order and 90-day supply. Filling a 90-day supply rather than monthly can reduce per-unit cost by 10% to 20% at many pharmacies, including CVS, Walgreens, and independent Mississippi pharmacies that offer multi-month pricing.

Compounded Progesterone Legality and Safety in Mississippi

Compounded progesterone is legal in Mississippi when prepared by a licensed 503A or 503B pharmacy in compliance with state and federal regulations. This is not a gray area.

The FDA's compounding framework under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act establishes the legal basis for compounding [2]. Section 503A permits traditional compounding pharmacies to prepare medications based on individual prescriptions. Section 503B permits outsourcing facilities to compound without patient-specific prescriptions but imposes current good manufacturing practice (cGMP) requirements.

Mississippi has several licensed 503A compounding pharmacies. Patients should verify that any compounding pharmacy they use holds a current Mississippi Board of Pharmacy license and is accredited by PCAB (Pharmacy Compounding Accreditation Board) or a similar body. Accreditation is voluntary but signals adherence to quality standards above the state minimum.

One clinical consideration with compounded progesterone: the FDA has noted that compounded drugs are not FDA-approved and do not undergo the same premarket safety and efficacy review as manufactured drugs [10]. The PEPI Trial [3] and other major studies used manufactured micronized progesterone (Prometrium or equivalent), not compounded formulations. While compounded micronized progesterone uses the same active ingredient (USP progesterone), differences in excipients, dissolution characteristics, and bioavailability are theoretically possible. Prescribers should weigh cost savings against these considerations, particularly for patients who require precise progesterone levels for endometrial protection.

A 2020 study published in Menopause found that serum progesterone levels achieved with compounded oral progesterone capsules were comparable to those achieved with manufactured Prometrium in a small crossover trial (N=28), though the authors cautioned that larger studies are needed [11]. Compounded progesterone remains a reasonable option for cost-sensitive patients when sourced from a reputable pharmacy.

Telehealth Access to Oral Micronized Progesterone in Mississippi

Mississippi permits telehealth prescribing of oral micronized progesterone. A patient can consult with a licensed prescriber via video or audio visit and receive a prescription sent to any Mississippi pharmacy, including compounding pharmacies.

Mississippi's telehealth laws, updated in 2021, allow prescribers to establish a patient-provider relationship via telehealth for most non-controlled substances [12]. Progesterone is not a controlled substance, so telehealth prescribing is straightforward. The prescriber must hold a valid Mississippi medical license or practice under the Interstate Medical Licensure Compact.

Telehealth expands access for patients in rural Mississippi. The state's 82 counties include many areas classified as medically underserved by HRSA [13]. Women in the Delta region, for example, may live 60 or more miles from the nearest OB-GYN or endocrinologist. Telehealth removes this geographic barrier, allowing a patient to see a hormone therapy specialist, receive a progesterone prescription, and have it filled at her local pharmacy or shipped from a mail-order pharmacy.

HealthRX offers telehealth hormone therapy consultations with board-certified physicians licensed in Mississippi. Patients can discuss progesterone options, dosing, and monitoring in a single visit.

Choosing Between Prometrium, Generic, and Compounded Progesterone

The decision between brand Prometrium, generic micronized progesterone, and compounded progesterone depends on insurance status, cost sensitivity, and clinical considerations.

Generic micronized progesterone is the default choice for most patients. It is FDA-approved, bioequivalent to Prometrium, widely available at Mississippi pharmacies, and costs $45 or less per month. Insurance coverage further reduces this cost to a $5 to $25 copay in most commercial plans.

Brand Prometrium makes sense only when a patient has a documented allergy or intolerance to inactive ingredients in generic formulations, or when a manufacturer savings card brings the out-of-pocket cost below the generic copay. Both scenarios are uncommon.

Compounded progesterone at $25 per month is the most affordable route. It is the right fit for uninsured patients who face the full cash price and for patients who need a peanut-free formulation (Prometrium and most generics contain peanut oil, while compounding pharmacies can use alternative bases like olive oil). The ACOG Practice Bulletin on hormone therapy acknowledges that compounded bioidentical hormones may be appropriate "when a patient cannot tolerate an FDA-approved product" but cautions that "compounded products should not be considered first-line therapy" [14].

For a Mississippi patient without insurance and without a specific clinical need for brand or compounded product, the practical path is: fill generic progesterone at a chain or independent pharmacy using a discount card, targeting a price of $15 to $35 per month.